bpc-157 interstitial cystitis pilot Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System Chemical structures of BPC 157
Description
Neurotransmitter Modulation This peptide appears to influence neurotransmitter systems, particularly dopamine and serotonin pathways
This helps in tailoring therapies to reduce flare-ups and protect joint integrity
However, long-term safety data is limited, and its full risk profile is not yet completely understood
aberrans and B
color and texture may vary slightly by lot Specifications Compound: NAD+ / MOTS-C / 5-Amino-1MQ Blend Amount: 100 mg / 10 mg / 10 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)
Retrieved May 15, 2025, from ChemicalBook (BPC-157 Product Page): ChemicalBook
